Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ELLENCE safely and effectively. See full prescribing information for ELLENCE. ELLENCE® (epirubicin hydrochloride injection) Initial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
ELLENCE is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer [see Clinical Studies (14.1)].
- generic_name
- epirubicin hydrochloride
- product_names
- epirubicin hydrochloride
- ndc
- 0009-5091, 0009-5091-01, 0009-5091-25, 0009-5093, 0009-5093-01, 0009-5093-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en